What is Roth Capital’s Forecast for OptimizeRx Q1 Earnings?
OptimizeRx Co. (NASDAQ:OPRX – Free Report) – Research analysts at Roth Capital issued their Q1 2026 earnings estimates for OptimizeRx in a research report issued to clients and investors on Wednesday, March 12th. Roth Capital analyst R. Baldry anticipates that the company will post earnings per share of ($0.19) for the quarter. The consensus estimate […]
OptimizeRx Co. (NASDAQ:OPRX – Free Report) – Research analysts at Roth Capital issued their Q1 2026 earnings estimates for OptimizeRx in a research report issued to clients and investors on Wednesday, March 12th. Roth Capital analyst R. Baldry anticipates that the company will post earnings per share of ($0.19) for the quarter. The consensus estimate […]
